Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606468738> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2606468738 endingPage "1047" @default.
- W2606468738 startingPage "1047" @default.
- W2606468738 abstract "1047 Objectives Availability of a positron emission tomography (PET) radioligand for the GABA transporter type 1 ( GAT-1) may facilitate the pre-synaptic imaging of GABA-ergic neurons. Changes in GABA-ergic neurotransmission are associated with a number of neurological (e.g. epilepsy) and psychiatric (e.g. schizophrenia, depression, Autism Spectrum Disorder, and anxiety) conditions. The objective of this work was to synthesize a GAT-1 selective PET radioligand based on a series of fluorinated unsymmetrical benzophenone-substituted nipecotic acid derivatives that have been recently described in the literature (Quandt G, et al. (2013) Bioorg Med Chem, 21, 3363). Methods The initial target molecule chosen for radiolabeling was 1-(2-{2-[4-fluoro-2-(4-fluorobenzoyl)phenyl]-vinyloxy}ethyl)nipecotic acid, which had demonstrated in vitro inhibition of GABA uptake similar to tiagabine (FDA approved high-affinity GAT-1 inhibitor) (Quandt G, et al., 2013). As precursor the ethyl ester of the chloro-substituted analog (1-(2-{2-[4-fluoro-2-(4-chloro-benzoyl)phenyl]vinyloxy}ethyl)nipecotic acid) was prepared. That precursor was then treated with [18F]KF/K2.2.2 in DMF at 130 °C for 30 minutes, and the intermediate fluorine-18 labeled ester hydrolyzed to the acid with sodium hydroxide. Results The [18F]fluorination was performed in a TRACERlab FXFN synthesis system. 1-(2-{2-[4-Fluoro-2-(4-[18F]fluorobenzoyl)phenyl]vinyloxy}ethyl)nipecotic acid was prepared in 13% radiochemical conversion from the chloro precursor. Conclusions This work demonstrates the successful synthesis of a novel nipecotic acid derivative as a potential PET radioligand for the GABA transporter GAT-1. This radioligand and related nipecotic acid derivatives may facilitate in vitro and in vivo studies to better understand the changes to GABA-ergic neurotransmission in diseases and support the development of new treatments and therapeutics.Acknowledgements: Research was supported by NIH grant R21NS086758." @default.
- W2606468738 created "2017-04-28" @default.
- W2606468738 creator A5032425304 @default.
- W2606468738 creator A5040863329 @default.
- W2606468738 creator A5046436153 @default.
- W2606468738 creator A5060562747 @default.
- W2606468738 date "2016-05-01" @default.
- W2606468738 modified "2023-09-27" @default.
- W2606468738 title "Synthesis of 1-(2-{2-[4-Fluoro-2-(4-[18F]fluorobenzoyl)phenyl]vinyloxy}ethyl)nipecotic Acid for PET imaging of GAT-1" @default.
- W2606468738 hasPublicationYear "2016" @default.
- W2606468738 type Work @default.
- W2606468738 sameAs 2606468738 @default.
- W2606468738 citedByCount "0" @default.
- W2606468738 crossrefType "journal-article" @default.
- W2606468738 hasAuthorship W2606468738A5032425304 @default.
- W2606468738 hasAuthorship W2606468738A5040863329 @default.
- W2606468738 hasAuthorship W2606468738A5046436153 @default.
- W2606468738 hasAuthorship W2606468738A5060562747 @default.
- W2606468738 hasConcept C170493617 @default.
- W2606468738 hasConcept C185592680 @default.
- W2606468738 hasConcept C2776055257 @default.
- W2606468738 hasConcept C2776219046 @default.
- W2606468738 hasConcept C55493867 @default.
- W2606468738 hasConcept C67847695 @default.
- W2606468738 hasConcept C71240020 @default.
- W2606468738 hasConceptScore W2606468738C170493617 @default.
- W2606468738 hasConceptScore W2606468738C185592680 @default.
- W2606468738 hasConceptScore W2606468738C2776055257 @default.
- W2606468738 hasConceptScore W2606468738C2776219046 @default.
- W2606468738 hasConceptScore W2606468738C55493867 @default.
- W2606468738 hasConceptScore W2606468738C67847695 @default.
- W2606468738 hasConceptScore W2606468738C71240020 @default.
- W2606468738 hasLocation W26064687381 @default.
- W2606468738 hasOpenAccess W2606468738 @default.
- W2606468738 hasPrimaryLocation W26064687381 @default.
- W2606468738 hasRelatedWork W1158109853 @default.
- W2606468738 hasRelatedWork W1964240089 @default.
- W2606468738 hasRelatedWork W2002042517 @default.
- W2606468738 hasRelatedWork W2006137388 @default.
- W2606468738 hasRelatedWork W2006203019 @default.
- W2606468738 hasRelatedWork W2007164248 @default.
- W2606468738 hasRelatedWork W2011102475 @default.
- W2606468738 hasRelatedWork W2012718293 @default.
- W2606468738 hasRelatedWork W2028923051 @default.
- W2606468738 hasRelatedWork W2045793277 @default.
- W2606468738 hasRelatedWork W2058857038 @default.
- W2606468738 hasRelatedWork W2063459685 @default.
- W2606468738 hasRelatedWork W2079066579 @default.
- W2606468738 hasRelatedWork W2111284067 @default.
- W2606468738 hasRelatedWork W2335705515 @default.
- W2606468738 hasRelatedWork W2740039218 @default.
- W2606468738 hasRelatedWork W2940372365 @default.
- W2606468738 hasRelatedWork W2981675869 @default.
- W2606468738 hasRelatedWork W3026143853 @default.
- W2606468738 hasRelatedWork W2110503896 @default.
- W2606468738 hasVolume "57" @default.
- W2606468738 isParatext "false" @default.
- W2606468738 isRetracted "false" @default.
- W2606468738 magId "2606468738" @default.
- W2606468738 workType "article" @default.